Angiotensin-II administration is useful for the detection of liver metastasis from pancreatic cancer during pharmacoangiographic computed tomography

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 22

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

178

HTML

1217

Figures (1-3)

166

Sum=1561

Jun 14, 2007 (publication date) through Jul 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jun 14, 2007; 13(22): 3080-3083
Published online Jun 14, 2007. doi: 10.3748/wjg.v13.i22.3080

Full Size Figure Download Figure

Figure 2 Comparison of the attenuation value of the enhanced liver metastasis in angiographic CT with and without angiotensin II (AT-II).

Citation: Ishikawa T, Ushiki T, Kamimura H, Togashi T, Tsuchiya A, Watanabe K, Seki KI, Ohta H, Yoshida T, Takeda K, Kamimura T. Angiotensin-II administration is useful for the detection of liver metastasis from pancreatic cancer during pharmacoangiographic computed tomography. World J Gastroenterol 2007; 13(22): 3080-3083
URL: https://www.wjgnet.com/1007-9327/full/v13/i22/3080.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i22.3080